Physician profile
Eric D Lance
NPI 1043292345
$6,022.78
in general payments reported to CMS, 2019-2025
24 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $59.45 · 2021: $271 · 2022: $4,866 · 2023: $125 · 2024: $317 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,632.56 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $406.46 | 2019-2025 | Phasix Mesh |
| Boston Scientific Corporation | $180.90 | 2020-2024 | Spyglass Discover |
| Medtronic, INC. | $91.27 | 2022 | |
| Conmed Corporation | $89.28 | 2021 | |
| Tela Bio, INC. | $70.22 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $64.17 | 2022-2025 | Collagenase Santyl, Renasys Touch |
| Carlsmed, INC. | $54.22 | 2022 | |
| Abbott Laboratories | $47.52 | 2022 | |
| Shire North American Group INC | $44.39 | 2019 | |
| Acell, INC. | $34.80 | 2019 | |
| Bioventus LLC | $32.75 | 2022 | |
| Integra Lifesciences Corporation | $31.46 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Olympus America INC. | $28.73 | 2019-2020 | |
| Csl Behring | $28.58 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $27.93 | 2023 | Activ.A.C., Promogran Prisma |
| Osiris Therapeutics INC. | $27.60 | 2019 | |
| Organogenesis INC. | $26.15 | 2022 | |
| Aroa Biosurgery Incorporated | $21.77 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.11 | 2024 | Exparel |
| Heron Therapeutics, INC. | $18.20 | 2021 | |
| Allergan, INC. | $17.66 | 2021 | |
| Sanara Medtech INC. | $13.81 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.